Four types of human coronaviruses (OC43, 229E, HKU1 and NL63) are highly seasonal and appear to transmit similarly to influenza A (H3N2) in the same population,...
In new laboratory experiments conducted by researchers from the University of Maryland, the University of Hong Kong and Harvard School of Public Health,...
According to a report by University of Göttingen researchers Christian Bommer and Sebastian Vollmer, the number of confirmed COVID-19 cases officially...
Healthcare professionals on the COVID-19 frontline are spending many hours a day wearing face masks, and many members of the general public are doing the...
An approach called the wastewater-based epidemiology (WBE), which is already recognized as an effective way to trace illicit drugs and obtain information...
A team of scientists from the Biomedicine Discovery Institute at Monash University and the Peter Doherty Institute of Infection and Immunity (Doherty Institute)...
A trial drug called APN01 or human recombinant soluble ACE2 (hrsACE2) can significantly block early stages of SARS-CoV-2 infections, according to a paper...
The Surviving Sepsis Campaign COVID-19 panel, which includes 36 experts from 12 countries, has issued new guidelines for health-care workers treating intensive...
A team of researchers at the University of Pittsburgh and Erasmus Medical Center Rotterdam has developed a potential vaccine against SARS-CoV-2, a novel...
Responding to an outbreak of SARS-CoV-2, a novel coronavirus that causes the COVID-19 disease, in December 2019, China banned travel to and from Wuhan...
Since humans haven’t previously been exposed to the SARS-CoV-2 coronavirus, our bodies aren’t well equipped to deal with being infected by it. A vaccine...
About 1 in 5 patients infected with SARS-CoV-2, a new coronavirus that causes the COVID-19 disease, are also infected with other respiratory viruses, according...
Two new papers published in the journal Antimicrobial Agents and Chemotherapy provide a summary of therapeutic compounds that showed potential in fighting...
Symptoms of COVID-19, the respiratory disease caused by the SARS-CoV-2 coronavirus, typically include a dry cough, fever and shortness of breath. But evidence...
Chemists at the Massachusetts Institute of Technology (MIT) have chemically synthesized a new peptide (a short protein fragment) that can bind to part...
Scientists from Gero Pte. Ltd., Singapore, have used a deep neural network to search for host-target acting antivirals among experimental and approved...
Researchers at the Treatment Center of PLA General Hospital in Beijing, China, have found that half of the patients they treated for mild COVID-19 disease...
Two recent studies concluded that snakes are the intermediate hosts of SARS-CoV-2, a novel coronavirus that causes the COVID-19 disease, and that four...
Drugs that are already approved by the U.S. Food and Drug Administration (FDA) could hold promise in fighting COVID-19, a respiratory disease caused by...
In December 2019, a novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China. In mid-January 2020,...
